[1]
2025. Evaluation of human placental-based cellular, acellular and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPSTIM clinical trial. International Journal of Tissue Repair. 1, Suppl 2 (Oct. 2025). DOI:https://doi.org/10.63676/mp9mtt23.